Janux Therapeutics, Inc. · NASDAQ:JANX
Janux Therapeutics, Inc. shareholders
As of Sep 30, 2026, 197 institutions reported holding Janux Therapeutics, Inc. Largest: Ra Capital Management, L.P., BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Janux Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 11.2M | no change | Nov 16, 2026 | |
| BlackRock | 6.53M | +400K | Nov 13, 2026 | |
| Vanguard | 4.01M | +452K | Nov 16, 2026 | |
| Prosight Management, LP | 2.94M | −861K | Nov 13, 2026 | |
| Federated Hermes, Inc. | 2.59M | +242K | Nov 12, 2026 | |
| Fidelity | 2.51M | +97,264 | Nov 10, 2026 | |
| State Street | 2.31M | −694K | Nov 12, 2026 | |
| Two Sigma | 1.85M | +638K | Nov 16, 2026 | |
| TCG Crossover Management, LLC | 1.79M | no change | Nov 16, 2026 | |
| Point72 Asset Management, L.P. | 1.58M | −414K | Nov 16, 2026 |